Active Ingredient History

  • Now
Diazoxide is a drug which was approved by FDA for the treatment of secondary hyperinsulinemia. The drug exerts its action by binding to SUR1 subunit of ATP-sensitive potassium channel that leads to the channel opening.   NCATS

  • SMILES: CC1=NC2=CC=C(Cl)C=C2S(=O)(=O)N1
  • Mol. Mass: 230.671
  • ALogP: 1.87
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$6.5003 - $11.0294
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

diazossido | diazoxide | diazoxido | diazoxidum | dizoxide | eudemine | eudimine | hyperstat | hypertonalum | mutabase | proglicem | proglycem | sch-6783 | srg-95213


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue